Mad in America
@mad-in-america.bsky.social did:plc:erf27a3qpjojwyohaq6na2zw
Rethinking Psychiatry Advocacy, Blogs, News, Podcasts and Resources. https://www.madinamerica.com
Bluesky’a katılma tarihi:
- Takipçi
- 860
- Takip edilen
- 34
- Post
- 1.181
- Sıralamaya girdiği gün
- 0
Özet
Mad in America (@mad-in-america.bsky.social), 18 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 860 takipçisi var, 34 hesabı takip ediyor ve 1.181 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
My new blog featured by @mad-in-america.bsky.social about what we can (need) to learn from fluoxetine trials for pediatric depression in order to judge other antidepressants commonly used for children and adolescents. A more elaborated version is on my website: ploederlm.github.io/blogs/fluoxe...
Postu gösterI met Eric at the Globalizing Schizophrenia conference I hosted in Berlin a while back - youtu.be/bOqIf0x6Rss?... - he's a lovely man and a fascinating speaker, look forward to listening to his podcast with Mad in America
Postu göster4. This is another example of motivated reasoning which can then be used by MAHA as example that mainstream psychiatry (or suicide prevention) is biased. Not good.
Postu göster3. The problem is that there is clearly no robust evidence that antidepressants reduce suicidal thoughts and behavior. Rather, there is evidence that antidepressants increase suicide risk www.psychiatrymargins.com/p/antidepres...
Postu göster2. The problematic claim: "A robust body of scientific evidence demonstrates that antidepressants are effective in treating acute depressive episodes, preventing future episodes, and reducing suicidal thoughts and behavior" They also "urge policymakers, clinicians...to ...address misinformation"
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
Bu hesap kimseyi bloklamıyor.